This bill requires the Department of Veterans Affairs (VA) to commission an independent study comparing the quality of mental health and addiction therapy care provided by VA health care providers versus non-VA providers. The study must assess key factors like health outcome improvements, use of evidence-based practices, coordination between providers, veteran satisfaction, and care for veterans with co-occurring conditions. It will cover various treatment settings - including telehealth, inpatient, and outpatient care - and must be completed within 18 months, with results published publicly. The study directly affects veterans receiving mental health or addiction therapy services through VA or non-VA providers. The bill does not change benefits or funding but aims to gather data to inform future care decisions.
This bill, S 641 (Safe and Affordable Drugs from Canada Act of 2025), would allow U.S. individuals to import certain prescription drugs from Canada under specific conditions. It requires drugs to come from FDA-certified Canadian pharmacies, match U.S.-approved drugs in active ingredients and form, be for personal use (not resale) in 90-day quantities, and include a U.S. physician's prescription. The bill excludes controlled substances, biologics, infused drugs, and other high-risk medications. It directly affects U.S. patients seeking lower-cost prescriptions who meet these criteria. The FDA would establish the certification process for Canadian pharmacies within 180 days of enactment.
S 483, the Responsibility in Drug Advertising Act of 2025, prohibits direct-to-consumer advertising of newly approved drugs for the first three years after approval, with a possible waiver for the third year if the drug sponsor demonstrates public health benefits. After the initial three years, the FDA may ban such advertising if post-approval safety data shows significant health risks. The bill requires the FDA to update its advertising regulations within one year of enactment to implement these rules. It applies only to drugs approved under specific FDA pathways after a one-year cutoff before the law's effective date.
The SEPSIS Act establishes a dedicated sepsis program within the Centers for Disease Control and Prevention (CDC) to improve prevention, detection, and treatment of sepsis in hospitals. It requires hospitals to adopt evidence-based sepsis protocols (like the Hospital Sepsis Program Core Elements), report on their implementation, and supports pediatric sepsis data collection. The bill authorizes $20 million annually from 2026-2030 to fund CDC efforts, including annual reports to Congress on hospital adoption rates, pediatric sepsis reduction, and a voluntary "honor roll" program recognizing top-performing hospitals. This directly affects hospitals through reporting requirements and CDC through new program responsibilities.
The HELP Copays Act requires that financial assistance from non-profit organizations or prescription drug manufacturers counts toward patients' annual out-of-pocket cost-sharing limits (like deductibles and copays) for certain prescription drugs. It directly affects individuals enrolled in group health plans or individual insurance who receive such assistance, ensuring payments from these sources reduce their total out-of-pocket spending. The bill amends key healthcare laws to include these payments in calculating cost-sharing thresholds, specifically for specialty drugs and drugs subject to utilization management (like prior authorization). It takes effect for plan years beginning in 2026 and does not change how utilization management tools are applied.
HR 5428 creates a federal grant program to support medical education for students planning to work in underserved areas. It provides $75 million annually (2026-2028) to accredited public medical schools in states with severe primary care physician shortages, prioritizing schools in states with multiple Indian Tribes and partnerships with tribal organizations or health centers. Grantees must use funds for community-based training, developing primary care programs emphasizing Tribal/rural underserved communities, faculty development, scholarships, and tracking graduates' practice locations. The bill directly affects medical schools and future physicians committed to serving Tribal, rural, or medically underserved communities after residency.
HR 5386, the Technical Assistance for Health Grants Act, requires the federal government to provide tailored technical support to entities receiving health grants under Section 2008 of the Social Security Act. It mandates assistance for grantees at all project stages, with specific provisions for Indian tribes, tribal organizations, territories, and demonstration projects, plus peer conferences to share best practices. The bill allocates $15 million for fiscal year 2026 to fund this technical assistance program and requires annual reports to Congress on the support provided. This direct policy change affects health grant recipients by improving their capacity to apply for and manage federal health funding. The amendments take effect October 1, 2025.
Tags
Tribal Nations
This bill increases Medicare reimbursement rates for critical access hospitals (CAHs) located in noncontiguous states (like Alaska or Hawaii) to 105% for specific services, up from the current 101%. It directly affects CAHs in these states by raising payments for inpatient care, outpatient services, ambulance transport, and skilled nursing facility services starting January 1, 2026. The key mechanism amends existing Social Security Act provisions to insert the higher 105% rate for services provided by CAHs in noncontiguous states. This policy change aims to address cost disparities for rural healthcare providers in geographically isolated areas.
The STORM Act establishes a federal system to rapidly deploy licensed health care professionals during emergencies using private technology platforms. It allows the President to certify private platforms that connect credentialed independent contractors (health care workers licensed in at least one state) and facilitates interstate licensure waivers for these workers when responding to federally declared emergencies. The bill requires annual reports to Congress on waiver usage and provides liability protections for participants who follow its procedures, except in cases of gross negligence. This directly affects health care platforms, independent contractors, and state emergency response systems by streamlining cross-state deployment during crises.
This bill establishes 12-month continuous enrollment for Medicaid and CHIP (Children's Health Insurance Program) beneficiaries, meaning individuals enrolled in these programs will not need to renew coverage annually. It removes the previous age limit of 19 for Medicaid coverage and updates language to refer to "individuals" instead of "children" in enrollment rules. The changes directly affect current and future Medicaid and CHIP recipients who would otherwise face annual renewal requirements. The policy takes effect one year after the bill's enactment, providing more stable health coverage for low-income families and children.
